Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
Conditions: Metastatic Breast Cancer
Sponsors: Optimer Biotechnology, Inc.
Phase II
January 19, 2012 Cancer - Breast Conditions: Lung Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase: n/a
May 5, 2011 Cancer - Lung Conditions: Fallopian Tubes, Ovarian Cancer, Peritoneal Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I
November 22, 2010 Cancer - Female Reproductive, Cancer - Peritoneal Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Sponsors: Gynecologic Oncology Group, National Cancer Institute (NCI)
Phase II
March 5, 2009 Cancer - Female Reproductive, Cancer - Peritoneal Conditions: Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
Sponsors: Gynecologic Oncology Group, National Cancer Institute (NCI)
Phase III
June 6, 2008 Cancer - Female Reproductive, Cancer - Peritoneal Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase II
May 13, 2002 Cancer - Prostate Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence
Conditions: Breast Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I
February 14, 2002 Cancer - Breast Vaccine Therapy Plus Biological Therapy in Treating Patients With Relapsed Prostate Cancer
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase II
May 6, 2001 Cancer - Prostate Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center
Phase I
May 6, 2001 Cancer - Prostate